Deciphering the Human Gut Microbiome of Urolithin Metabotypes: Association with Enterotypes and Potential Cardiometabolic Health Implications

The gut microbiota ellagitannin-metabolizing phenotypes (i.e., urolithin metabotypes [UMs]) are proposed as potential cardiovascular disease (CVD) risk biomarkers because the host blood lipid profile is reported to be associated with specific UMs. However, the link for this association remains unkno...

Descripción completa

Detalles Bibliográficos
Autores: Romo Vaquero, María, Cortés-Martín, Adrián, Loria-Kohen, Viviana, Ramírez de Molina, Ana, García Mantrana, Izaskun, Collado, María Carmen, Espín de Gea, Juan Carlos, Selma, María Victoria
Tipo de recurso: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2019
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/341206
Acceso en línea:http://hdl.handle.net/10261/341206
https://api.elsevier.com/content/abstract/scopus_id/85057953894
Access Level:acceso abierto
Palabra clave:Urolithins
Coriobacteriaceae
Cardiometabolic health
Gut microbiota
Metabotypes
Polyphenols
Descripción
Sumario:The gut microbiota ellagitannin-metabolizing phenotypes (i.e., urolithin metabotypes [UMs]) are proposed as potential cardiovascular disease (CVD) risk biomarkers because the host blood lipid profile is reported to be associated with specific UMs. However, the link for this association remains unknown so far.

Similares en LA Referencia